Spin-off companies
of Masaryk university

manufacture of scientific instruments for surface analysis of solid materials and provision of measurement services

The company was founded in 2007 as a spin-off company of Masaryk University to take over the established production of the See System instrument for contact angle and surface energy measurements. Although the See System has remained the company's flagship scientific instrumentation, the company has expanded its portfolio to include diagnostics of other surface properties, such as the self-cleaning ability of photocatalytic materials or water permeability.

computer services and software licensing for the prediction of binding affinity or related problems

AI|ffinity is a contract research organization offering computational services and software licensing for binding affinity prediction or related problems (e.g., hit discovery, track optimization, off-target prediction, pharmacophore modeling). Its technology is based on artificial intelligence, cheminformatics and nuclear magnetic resonance. It was established as a spin-off of Masaryk University at the end of 2021.

production and visualization of spatial information as a basis for spatial planning and decision-making

Corporate team of Altimapo is made up of cartographers and social geographers who have extensive experience in projects for both the public and private spheres. The core of their activities lies in the production and visualisation of spatial information as a basis for spatial planning and decision-making in the broadest sense. Thanks to its connection to academic research, it cooperates with urban planners, economists, sociologists and marketing experts.

development of compounds (CK1 inhibitors) as drugs for some types of leukemias, lymphomas and solid tumors

CasInvent Pharma is developing proprietary compounds that play an important role in serious cancer processes. CasInvent Pharma was founded in 2020 as a spin-off of Masaryk University with the support of the i&i Prague BioInnovation Center. Its original goal was to test compounds that block the enzyme casein kinase 1 (CK1), which is responsible for, among other things, the migration of leukemia cells to lymphoid organs.

production of highly specific active enzymes for the needs of optically active substance manufacturers

Enantis was established as the first biotechnology spin-off of Masaryk University in 2006. The core values of the company are based on a complete in-house development cycle - from protein design using state-of-the-art software to delivery of the final product. It provides unique protein optimization and new product development services for smart proteins. Enantis works closely with Loschmidt Laboratories.

non-invasive objective stress measurement in real time

Entrant has developed a method to measure stress. It can measure it in real time and without taking samples (blood, saliva, etc.). A unique mathematical equation works with common physiological data to determine stress levels. Primarily developed to identify astronaut stress, the method has been tested in the stressful conditions of Antarctica. As a spin-off of Masaryk University, the company has been listed since 2020.

development of applications for language learning using artificial intelligence

EVE Technologies develops innovative e-learning applications. It focuses primarily on the development of tools for language learning. The company works with knowledge from the fields of linguistics, AI and NLP in its applications. The most significant result is the development of an application for teaching non-native speakers of Czech, CzechME, developed in cooperation with Masaryk University. It has spin-off status since 2022.

information and editorial systems, commercial calculations and consulting in the field of biostatistics

The Institute of Biostatistics and Analysis (IBA) is a spin-off company of MU since 2014. It focuses on clinical research project management, real-world evidence (RWE) projects and clinical trial management (especially non-interventional clinical trials and medical registries).

development of network cards and hardware solutions

Magmio is used by merchants all over the world. The company offers an implementation of a flexible FPGA solution that enables traders to achieve the full potential of algorithmic trading - with an unusually short time to market and without the need for in-house expertise in the technology.

evidence-based medicine in eHealth to support mental health

MilkyWay Be Well, in collaboration with LF MU, has developed MyWay Analytix, an online software for analysing and supporting mental health in the work environment, which integrates evidence-based medicine and modern technologies in the field of mental eHealth.

innovative systems for big data processing and analysis

Mycroft Mind is a technology company that aims to deliver and build a portfolio of innovative systems for processing and analyzing big data in the new era of data collected from smart grid or Internet of Things (IoT) sources.

development and production of plasma chemical equipment

ROPLASS is dedicated to the development of innovative and value-added technologies for the surface treatment of polymer materials used in the automotive, textile, film, paper, glass and other industries using atmospheric plasma.

development of diagnostic kits and procedures for cancer prediction

Sofigen is a molecular biology company that focuses on advanced diagnostics, risk determination and prevention of cancer and congenital genetic diseases. It offers examinations in these areas not only to physicians and other health professionals, but to all interested members of the public.

comprehensive solutions in the field of computer network monitoring and security

(dissolved X/2015 due to merger with INVEA TECH, a.s.)

software tool for analysis and visualization of tunnels and channels in protein structures

(cooperation with Masaryk University was terminated)

development and sale of operating system and programs simulating operating system environment

(the company entered liquidation on 1 January 2021 based on the decision of the general meeting of the company)

smart solutions for healthy network operation

(exit 2020, sale to US company Kemp Technologies)

development of chemoinformatics and bioinformatics software

(cooperation with Masaryk University ended)

data network security

(dissolution X/2015, successor Flowmon + Netcope)

development of plasma systems for machining metal, plastic, wood and glass surfaces

(license agreement terminated as of 15. 3. 2018)

development of network cards and hardware solutions

(formed by spin-off from Flowmon under the name Netcope Technologies, a.s. | from 15 February 2022 the company is registered under the name Magmio a.s.)

production, trade and services in the field of molecular and cell biology

(licence expired on 31.12.2021)